These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 8998916)
1. [HIV: to administer protease inhibitors early]. Dtsch Med Wochenschr; 1996 Dec; 121(49):A49. PubMed ID: 8998916 [No Abstract] [Full Text] [Related]
2. [HIV: less resistance due to combined treatment]. Dtsch Med Wochenschr; 1996 Dec; 121(49):A47-8. PubMed ID: 8998914 [No Abstract] [Full Text] [Related]
3. Protease inhibitors and prevention of cross resistance. Levin J AIDS Treat News; 1995 Oct; (no 232):1-3. PubMed ID: 11362875 [TBL] [Abstract][Full Text] [Related]
4. Ritonavir and saquinavir combination: 12-week data at ICAAC. James JS AIDS Treat News; 1996 Oct; (No 256):3. PubMed ID: 11363880 [TBL] [Abstract][Full Text] [Related]
5. Drug combination shows benefits for AIDS patients with history of taking AZT. AIDS Patient Care STDS; 1996 Jun; 10(3):185-6. PubMed ID: 11361628 [No Abstract] [Full Text] [Related]
6. Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine. Michelet C; Bellissant E; Ruffault A; Arvieux C; Delfraissy JF; Raffi F; Bazin C; Renard I; Sébille V; Chauvin JP; Dohin E; Cartier F Clin Pharmacol Ther; 1999 Jun; 65(6):661-71. PubMed ID: 10391672 [TBL] [Abstract][Full Text] [Related]
7. Cure or control of HIV/AIDS? Collins DO; Sakamoto A Med Hypotheses; 1997 Jun; 48(6):489-90. PubMed ID: 9247891 [No Abstract] [Full Text] [Related]
8. Combination study of Invirase and Norvir starting. AIDS Patient Care STDS; 1996 Jun; 10(3):187. PubMed ID: 11361633 [No Abstract] [Full Text] [Related]
9. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen. Cameron DW; Becker S; King MS; da Silva B; Klein C; Tokimoto D; Foit C; Calhoun D; Bernstein B; Hanna GJ J Antimicrob Chemother; 2007 May; 59(5):957-63. PubMed ID: 17350990 [TBL] [Abstract][Full Text] [Related]
10. Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy. Mathez D; Bagnarelli P; Gorin I; Katlama C; Pialoux G; Saimot G; Tubiana P; De Truchis P; Chauvin JP; Mills R; Rode R; Clementi M; Leibowitch J Antivir Ther; 1997 Jul; 2(3):175-83. PubMed ID: 11322272 [TBL] [Abstract][Full Text] [Related]
11. FDA Committee recommends clearance for HIVID combination therapy. AIDS Patient Care STDS; 1996 Jun; 10(3):186. PubMed ID: 11361630 [No Abstract] [Full Text] [Related]
12. Combination shows reduction in viral levels. AIDS Patient Care STDS; 1996 Jun; 10(3):184. PubMed ID: 11361623 [No Abstract] [Full Text] [Related]
13. [Nevirapine: a new principle of action against HIV]. Dtsch Med Wochenschr; 1996 Dec; 121(49):A48-9. PubMed ID: 8998915 [No Abstract] [Full Text] [Related]
14. Head-to-head study of protease inhibitors. AIDS Patient Care STDS; 1998 Jan; 12(1):63-4. PubMed ID: 11361890 [No Abstract] [Full Text] [Related]
15. Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS clinical trials group 229. Schapiro JM; Lawrence J; Speck R; Winters MA; Efron B; Coombs RW; Collier AC; Merigan TC J Infect Dis; 1999 Jan; 179(1):249-53. PubMed ID: 9841849 [TBL] [Abstract][Full Text] [Related]
16. Invirase resistance/cross-resistance data released. AIDS Patient Care STDS; 1996 Jun; 10(3):185. PubMed ID: 11361626 [No Abstract] [Full Text] [Related]